Name | Norfluoxetine hydrochloride |
---|---|
Synonyms |
3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,hydrochloride
Benzenepropanamine, γ-(4-(trifluoromethyl)phenoxy)-, hydrochloride 3-Phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine hydrochloride (1:1) Benzenepropanamine, γ-[4-(trifluoromethyl)phenoxy]-, hydrochloride (1:1) |
Description | Norfluoxetine hydrochloride is an active N-demethylated metabolite of Fluoxetine. Fluoxetine is a selective serotonin (5-HT) reuptake inhibitor that is metabolized to Norfluoxetine hydrochloride by cytochrome P450 (CYP) 2D6, CYP2C19, and CYP3A4. Norfluoxetine hydrochloride inhibits 5-HT uptake and inhibits CaV3.3 T current (IC50 = 5 μM). Norfluoxetine hydrochloride has anticonvulsant activity[1][2][3][4]. |
---|---|
Related Catalog | |
Target |
5-HT Receptor Cav3.3:5 μM (IC50) |
In Vivo | Pretreatment with Fluoxetine or Norfluoxetine hydrochloride (20mg/kg s.c.), as well as Phenytoin (30 mg/kg s.c.) and Clonazepam (0.1mg/kg s.c.) significantly increases both the rate and duration of survival, demonstrating a significant protective effect against Pentylenetetrazol-induced epilepsy[1]. |
References |
Density | 1.204g/cm3 |
---|---|
Boiling Point | 381.1ºC at 760 mmHg |
Molecular Formula | C16H17ClF3NO |
Molecular Weight | 331.760 |
Flash Point | 184.3ºC |
Exact Mass | 331.095062 |
PSA | 35.25000 |
LogP | 5.67660 |
Water Solubility | H2O: >4 mg/mL |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |